Horama

Gene therapy medicinal products for rare ophthalmological diseases

Total raised

€4.0M

€4,000,000

Funding rounds

Investors

distinct backers

Active since

2016-06

latest 2016-06

Funding by year

EUR raised per year

High confidence

Raise-next likelihood16

base rate 44% for Series A

Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.

1 rounds

Date	Stage	Amount	Investors
2016-07-01	Series A	€4.0M	GO Capital,Omnes Venture Capital	View deal →

same sector or country